<DOC>
	<DOC>NCT02168296</DOC>
	<brief_summary>The study is designed to explore the pharmacokinetics of a Plant-based ingredient in two different matrices, at different dose levels.</brief_summary>
	<brief_title>Pharmacokinetics of Plant-based Ingredient</brief_title>
	<detailed_description />
	<criteria>Healthy males, age at start of the study 20 and 50 years Body mass index (BMI) ≥ 20,0 and ≤ 25,0 kg/m2 Apparently healthy: no medical conditions which might affect the study measurements, absorption, metabolism and distribution (including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal surgery and inflammatory diseases) Fasting blood glucose value of subjects is ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62110 mg/dl) at screening Any history of diabetes, hyper (or hypo) glycemia or other disorder of glucose metabolism Any history of gastrointestinal disorders (including frequent diarrhoea for example) Blood donation in the past 2 months Reported participation in another nutritional or biomedical trial 3 months before the prestudy examination or during the study Reported intense sporting activities &gt; 10 h/w Consumption of &gt; 21 alcoholic drinks in a typical week Not being used to eat breakfast Reported use of any nicotine containing products in the six months preceding the study and during the study itself Use of medication which interferes with study measurements Reported dietary habits: medically prescribed diet, slimming diet Not used to eat 3 meals a day Vegetarian Reported weight loss/gain (&gt;10%) in the last six month before the study; Allergy or intolerance to food products and aversion to food products;</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Blood glucose</keyword>
	<keyword>subjects</keyword>
</DOC>